Bengaluru: Bengaluru-headquartered biotechnology company Biocon on Saturday announced the launch of a biological drug researched, developed and manufactured in the country to treat chronic plaque pso

Bengaluru-based Biocon is planning to forge partnerships as well as leverage existing alliances to augment the access and penetration of its biosimilar molecules.

"We are investing in augmentin

An expected licencing income helped Biocon, India's top-listed biotechnology company, post better-than-expected quarterly profit and lift its shares more than 4 per cent, but it said the global busine

Biotechnology major Biocon on Friday reported a dip of 2.98 per cent in its consolidated net profit at Rs 97.8 crore for the quarter ended March 31, 2012. This was mainly on account of rise in expendi